Procter & Gamble CFO Andre Schulten sells $568,860 of stock

Procter & Gamble's CFO, Andre Schulten, divested 3,914 shares of the company's stock on October 5, 2026, generating $568,860 from the transaction. The sale was primarily to satisfy tax liabilities associated with the settlement of a Restricted Stock Unit Award. Following the sale, Schulten personally owns 65,618.0097 shares of Procter & Gamble common stock, with an additional 7,604.419 shares held indirectly through a Retirement Plan Trustee, reflecting adjustments up to September 30, 2026.

Concurrently, Procter & Gamble experienced an upgrade from Evercore ISI to an Outperform rating from In Line, reflecting a positive sales outlook and an upward revision of their Q1 2027 organic sales growth estimate to around 3%, surpassing the previous consensus of 2%. Furthermore, Moody's upgraded the company's outlook to positive from stable, underscoring P&G's solid cash flow and earnings growth, driven by their strategic emphasis on globally scalable products and robust credit metrics.

However, the company faced challenges with the Italian antitrust authorities, which led to the modification of its advertising claims for the Braun Skin i-Expert IPL hair removal device to remove any references to a two-year hair-free outcome. Despite these developments, Bernstein SocGen Group raised its price target for Procter & Gamble to $149.00, maintaining a Market Perform rating, acknowledging the company's substantial marketing investments between 2021 and 2026.

Additionally, RBC Capital reaffirmed its Outperform rating on Procter & Gamble, highlighting a 25 basis point increase in U.S. market share for the September quarter-to-date period.